Bryan Bedford disclosed purchase in Regeneron Pharmaceuticals

Bryan Bedford reported a purchase transaction in Regeneron Pharmaceuticals (REGN) on 2025-07-10.

Signal
Congress Trade
Action
Buy
Capital
Disclosure amount unavailable

Why it matters

Congress disclosures can highlight policy-adjacent trading activity. This card is generated from canonical action facts, not request-time scraping.

Evidence